The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in ...

Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

Home to excellent research institutions, a thriving life sciences community, a strong collaborative culture, and a strategic location at the heart of Europe, Ghent is now investing in cutting-edge ...

While non-exhaustive, this list offers an overview of the year’s biotech events taking place around the world, aimed at partnering and connecting with decision makers in biopharma. If there is a ...

Last week nearly 6000 people from more than 3200 companies gathered in Vienna for the annual BIO-Europe partnering conference. Over three days, more than 32,000 meetings were facilitated between ...

The need for change in Novo Nordisk’s operations became irrefutably clear in July, when the company named its new CEO, Maziar Mike Doustdar, and simultaneously issued a profit warning for its ...

The U.K. has had a stronghold on the biopharma and healthcare industry for a long time and remains one of the top hubs for life science research. So, Merck’s decision to back out of its $1 billion ...

A company that hardly needs an introduction is Eli Lilly, but what has it been up to lately, and what’s its pipeline strategy? Over the past year, Lilly has mixed headline-grabbing science with ...